Quest Diagnostics (DGX) net assets (shareholders' equity)

Net assets · fiscal 2025
$7.17B

Quest Diagnostics (DGX) had net assets of $7.17B at the end of fiscal 2025 (December 31, 2025). That is 5.8% higher than the $6.78B of fiscal 2024. Figures as of 19 Nov 2026, 07:39 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Net assets, fiscal 2025
$7.17B
Change on fiscal 2024
+5.8%
Growth, 5 years
+1.2% a year
Growth, 10 years
+4.3% a year
Highest on record
$7.17Bfiscal 2025
Lowest on record
$3.35Bfiscal 2007
Fiscal years on record
192007–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Quest Diagnostics net assets (shareholders' equity), in more detail

Over the five fiscal years to 2025 net assets grew at a compound 1.2% a year; over ten years the rate was 4.3% a year. Across the 19 fiscal years on record (2007–2025), the highest was $7.17B in fiscal 2025 and the lowest $3.35B in fiscal 2007.

History · 19 fiscal years

Net assets by fiscal year

Quest Diagnostics net assets (shareholders' equity), year by year

Quest Diagnostics (DGX) net assets (shareholders' equity) by fiscal year
Fiscal yearNet assetsChangeYear ended
2025$7.17B 5.8% up
2024$6.78B 7.5% up
2023$6.31B 7.0% up
2022$5.89B 8.6% down
2021$6.44B 4.7% down
2020$6.76B 19.8% up
2019$5.64B 8.1% up
2018$5.22B 6.0% up
2017$4.92B 6.3% up
2016$4.63B 1.2% down
2015$4.68B 8.9% up
2014$4.30B 8.9% up
2013$3.95B 5.2% down
2012$4.16B 12.7% up
2011$3.69B 8.4% down
2010$4.03B 1.1% up
2009$3.99B 10.7% up
2008$3.60B 7.7% up
2007$3.35B—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Net assets is shareholders' equity on the balance sheet at the fiscal year-end: total assets minus total liabilities, also called book value.

How to read it

Large buybacks and write-offs shrink it without the business getting worse, so a falling or negative figure needs the reason before a verdict.

Net assets at health care companies of similar size

Net assets of Quest Diagnostics and comparable companies
CompanyNet assetsFiscal year
Labcorp Holdings LH$8.62B2025
DexCom DXCM$2.75B2025
Koninklijke Philips PHG€10.96B2025
Roivant Sciences ROIV$4.53B2026
West Pharmaceutical Services WST$3.18B2025
Quest Diagnostics DGX$7.17B2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on DGX

Quest Diagnostics, figure by figure

Quest Diagnostics (DGX) overview: price, valuation and scorecardAll health care companies by market value

Quest Diagnostics net assets (shareholders' equity): questions and answers

What are Quest Diagnostics's net assets?

Quest Diagnostics (DGX) had net assets of $7.17B at the end of fiscal 2025 (December 31, 2025). That is 5.8% higher than the $6.78B of fiscal 2024.

What is the growth rate of Quest Diagnostics's net assets?

Over the five fiscal years to 2025 net assets grew at a compound 1.2% a year; over ten years the rate was 4.3% a year.

What are the highest and lowest net assets figures on record for Quest Diagnostics?

Across the 19 fiscal years on record (2007–2025), the highest was $7.17B in fiscal 2025 and the lowest $3.35B in fiscal 2007.

How is Quest Diagnostics's net assets calculated?

Net assets is shareholders' equity on the balance sheet at the fiscal year-end: total assets minus total liabilities, also called book value. For Quest Diagnostics it is on record here for 19 fiscal years, 2007 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Quest Diagnostics (DGX) net assets (shareholders' equity)”, data as of 19 November 2026. https://funkfolio.com/stock/DGX/net-assets

Underlying data: the company's filings with the SEC and Yahoo Finance.